盧國城 主任

最高學歷:國防醫學院醫學士

研究領域:

  • 慢性腎臟病(含高血壓、糖尿病、腎病症候群)預防與治療
  • 透析治療(血液透析、腹膜透析)、移植照顧
  • 腎臟病(尿毒症)骨骼病變
  • 次發性副甲狀腺功能亢進
  • 維他命D臨床運用
  • 各類骨骼疾病(含骨骼疏鬆)內科療法

分機:3117

電子信箱:tch33730@tzuchi.com.tw

  • 慢性腎臟病(含高血壓、糖尿病、腎病症候群)預防與治療
  • 透析治療(血液透析、腹膜透析)、移植照顧
  • 腎臟病(尿毒症)骨骼病變
  • 次發性副甲狀腺功能亢進
  • 維他命D臨床運用
  • 各類骨骼疾病(含骨骼疏鬆)內科療法

轉譯醫學之生物資料庫運用團隊

  • 內外科團隊:心臟外科宋鎮宇醫師、消化外科陳彥志醫師、一般外科張健輝醫師、骨科胡家榮醫師、直腸外科呂宗儒醫師,風濕免疫科 陳政宏主任
  • 研究部團隊:共研中心盧國城主任、共同實驗室蔡國旺主任、研究型主治醫師胡萬炯醫師
  • 主要目標:整合人體生物資料庫、臨床與基礎醫學之研究資源,探討慢性腎臟病之透析用廔管之血管病變、慢性腎臟病礦物質代謝與骨病變、癌症抗藥性與轉移、癌症幹細胞之致病機轉以及生物標誌之開發,希望提供病患優質的醫療服務並發展成為國際級的癌症研究或慢性腎骨病變之研究機構。

IgA Nephropathy研究

  • 台灣地區 計畫總主持人 (National leader)
  • The ALIGN Study: A Phase 3, Randomized, Double-blind, Placebo –controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function

Secondary Hyperparathyroidism研究

  • 東亞地區 (中國大陸、韓國、香港、台灣) 計畫總顧問
  • 台灣地區 計畫總主持人
  • KHK7580 Orchestra Study
  • Official Title:   A Phase 3, Randomized, Double-Blind, Intra-Subject Dose-Adjustment, Parallel-Group Study of KHK7580 and Cinacalcet Hydrochloride in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis

尿毒搔癢症研究

  • 台灣地區 計畫總主持人 (National leader, 5 sites)
  • 血液透析患者接受AST-120治療對尿毒搔癢症之療效評估
  • 美國人工器官醫學年會論文獎 (1991) 
  • 腎臟醫學會陳萬裕教授論文獎 (1993)
  • 歐洲腎臟醫學會年度論文獎 (1995)
  • 國科會研究獎(1995) 
  • 發表次發性副甲狀腺功能亢奮論文獲得全球排名第一、第二、第三、第五、第 15 名(2012)
  • 美國亞利桑那州 A.T. Still University 訪問教授 (2012) 
  • 台北醫學大學 客座教授 (2013~) 
  • 國防醫學院 合聘教授 (2015~) 
  • 三軍總醫院 榮譽教授 (2016~)
  • 全球慢性腎病礦物質骨骼代謝治療指引顧問(2017)
  1. The MTNR1A mRNA is stabilized by the cytoplasmic hnRNPL in renal tubular cells.Huang YS, Lu KC, Chao HW, Chen A, Chao TK, Guo CY, Hsieh HY, Shih HM, Sytwu HK, Wu CC.J Cell Physiol. 2021 Mar;236(3):2023-2035. doi: 10.1002/jcp.29988.
  2. Effectiveness of a self-management program in enhancing quality of life, self-care, and self-efficacy in patients with hemodialysis: A quasi-experimental design.Lee MC, Wu SV, Lu KC, Liu CY, Liang SY, Chuang YH.Semin Dial. 2021 Feb 2. doi: 10.1111/sdi.12957.
  3. Taking Sleeping Pills and the Risk of Chronic Kidney Disease: A Nationwide Population-Based Retrospective Cohort Study.Liao CY, Chung CH, Lu KC, Cheng CY, Yang SS, Chien WC, Wu CC.Front Pharmacol. 2021 Jan 25;11:524113. doi: 10.3389/fphar.2020.524113.
  4.  Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy.Ho P, Zheng JQ, Wu CC, Hou YC, Liu WC, Lu CL, Zheng CM, Lu KC, Chao YC.Int J Med Sci. 2021 Jan 1;18(2):314-324. doi: 10.7150/ijms.51935.
  5. Therapeutic Effect of Calcimimetics on Osteoclast–Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone DiseaseKuo‐Chin Hung, Jia‐Feng Chang, Yung‐Ho Hsu, Chih‐Yu Hsieh, Mai‐Szu Wu, Mei‐Yi Wu, I‐Jen Chiu, Ren‐Si Syu, Ting‐Ming Wang, Chang‐Chin Wu, Lie‐Yee Hung, Cai‐Mei Zheng, and Kuo‐Cheng Lu*Int. J. Mol. Sci. 2020, 21, 8712; doi:10.3390/ijms21228712
  6. Novel Evidence of Acute Kidney Injury in COVID-19. Chueh TI, Zheng CM, Hou YC, Lu KC*.J Clin Med. 2020 Nov 3;9(11):E3547
  7. Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease.Cheng TH, Ma MC, Liao MT, Zheng CM, Lu KC, Liao CH, Hou YC, Liu WC, Lu CL.Toxins (Basel). 2020 Oct 29;12(11):E684 
  8. Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal ProtectionYi-Chou Hou,Cai-Mei Zheng, Tzung-Hai Yen and Kuo-Cheng Lu*Int. J. Mol. Sci. 2020, 21(21), 7833 
  9. Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway.Liu WC, Shyu JF, Lin YF, Chiu HW, Lim PS, Lu CL, Zheng CM, Hou YC, Chen PH, Lu KC*.Int J Mol Sci. 2020 Oct 11;21(20): E7483. 
  10. Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease. Jenn-Yeu Song, Ta-Chung Shen, Yi-Chou Hou, Jia-Feng Chang, Chien-Lin Lu, Wen-Chih Liu, Po-Jui Chen, Bo-Hau Chen, Cai-Mei Zheng, Kuo-Cheng Lu*Int J Mol Sci. 2020 Aug 31;21(17):6294. 
  11. The study of isotopic enrichment of water in human plasma and erythrocyteYuan-Hau Lin, Ying-Chi Wang, Mai-Szu Wu, Kuo-Cheng Lu, Hsin-Yi Lin, Hsien-Shou Kuo, Geen-Dong Chang, Chun-Mao Lin, Chiao long Hsiao.FASEB J. 2020 Aug 10. doi: 10.1096/fj.202000388RR 
  12. Influence of intradialytic systolic blood pressure changes on arteriovenous access thrombosis in maintenance hemodialysis patients.Zheng CM, Chiu YP, Hou YC, Liu YM, Wu MS, Lin YF, Lo YL, Lu KC, Hsu YH, Wang YH.Int J Clin Pract. 2020 Oct 28:e13799 
  13. TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular DamageChien-Lin Lu, Chun-Hou Liao, Kuo-Cheng Lu, Ming-Chieh MaInt J Mol Sci. 2020 Aug 27;21(17):6212. 
  14. The Modulating Effect of Dietary Protein Intake on Mortality in Long-term Hemodialysis Patients: A Nationwide Population-based Study.Zheng CM, Hsu YH, Lu CL, Chen HH, Lu KC, Chen JS, Chen KC, Peng CC, Lin YF, Hsu CC, Wu MS, Lin YC.Int J Clin Pract. 2020 Oct 3: e13747. 
  15. The effect of a self-management program on renal function control in patients with hemodialysis in Taiwan: A longitudinal randomized controlled trial.Lee MC, Wu SV, Lu KC, Liu CY, Liu WI, Liu JH.Jpn J Nurs Sci. 2020 May 10:e12345. 
  16. Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor.Liu WC, Shyu JF, Lim PS, Fang TC, Lu CL, Zheng CM, Hou YC, Wu CC, Lin YF, Lu KC*.Int J Mol Sci. 2020 May 15;21(10):E3486. doi: 10.3390/ijms21103486. 
  17. Scavenging Intracellular ROS Attenuates p-Cresyl Sulfate-Triggered Osteogenesis through MAPK Signaling Pathway and NF-B Activation in Human Arterial Smooth Muscle CellsJia-Feng Chang, Chih-Yu Hsieh, Jian-Chiun Liou, Shih-Hao Liu, Chi-Feng Hung, Kuo-Cheng Lu, Chih-Cheng Lin, Chang-Chin Wu, Shuk-Man Ka, Li-Li Wen, Mai-Szu Wu, Cai-Mei Zheng and Wen-Chin KoToxins 2020, 12, 472 
  18. Therapeutic Targeting of Aristolochic Acid Induced Uremic Toxin Retention, SMAD 2/3 and JNK/ERK Pathways in Tubulointerstitial Fibrosis: Nephroprotective Role of Propolis in Chronic Kidney DiseaseJia-Feng Chang, Chih-Yu Hsieh, Kuo-Cheng Lu, Yue-Wen Chen, Shih-Shin Liang, Chih-Cheng Lin, Chi-Feng Hung, Jian-Chiun Liou and Mai-Szu WuToxins 2020, 12, 364 
  19. Association Between Gout and Injury Risk: A National Retrospective Cohort Study.Ou SH, Chou CL, Lin CW, Chien WC, Fang TC, Lu KC, Chen JS.Int J Environ Res Public Health. 2020 May 23;17(10):E3679. doi: 10.3390/ijerph17103679. 
  20. Uremic Vascular Calcification Is Correlated With Oxidative Elastic Lamina Injury, Contractile Smooth Muscle Cell Loss, Osteogenesis, and Apoptosis: The Human Pathobiological Evidence.Chang JF, Liu SH, Lu KC, Ka SM, Hsieh CY, Ho CT, Lin WN, Wen LL, Liou JC, Chang SW, Wu CC, Wang TM, Li YY.Front Med (Lausanne). 2020 Mar 24; 7: 78. doi: 10.3389/fmed.2020.00078.  
  21. The Role of Vitamin D in Modulating Mesenchymal Stem Cells and Endothelial Progenitor Cells for Vascular Calcification.Hou YC, Lu CL, Zheng CM, Liu WC, Yen TH, Chen RM, Lin YF, Chao CT, Lu KC*.Int J Mol Sci. 2020 Apr 2;21(7). pii: E2466. doi: 10.3390/ijms21072466.  
  22. Tc-99m TRODAT-1 SPECT is a Potential Biomarker for Restless Leg Syndrome in Patients with End-Stage.Hou YC, Fan YM, Huang YC, Chen RM, Wang CH, Lin YT, Yen TH, Lu KC*, Lin YF.J Clin Med. 2020 Mar 24;9(3). pii: E889. doi: 10.3390/jcm9030889. 
  23. Sirtuin-1 and Its Relevance in Vascular Calcification.Lu CL, Liao MT, Hou YC, Fang YW, Zheng CM, Liu WC, Chao CT, Lu KC*, Ng YY.Int J Mol Sci. 2020 Feb 26;21(5). pii: E1593. doi: 10.3390/ijms21051593.  
  24. Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan.Lin FJ, Shyu KG, Hsieh IC, Huey-Herng Sheu W, Tu ST, Yeh SJ, Chen CI, Lu KC, Wu CC, Shau WY, Inocencio TJ, Wen YC, Yeh HI.J Formos Med Assoc. 2020 Feb 18. pii: S0929-6646(20)30014-0. 
  25. The Epigenetic Landscape of Vascular Calcification: An Integrative Perspective.Hou YC, Lu CL, Yuan TH, Liao MT, Chao CT, Lu KC*.Int J Mol Sci. 2020 Feb 1;21(3). pii: E980. doi: 10.3390/ijms21030980. Review. 
  26. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.Wang AY, Akizawa T, Bavanandan S, Hamano T, Liew A, Lu KC, Lumlertgul D, Oh KH, Zhao MH, Ka-Shun Fung S, Obi Y, Sumida K, Choong LHL, Goh BL, Hao CM, Kwon YJ, Tarng DC, Zuo L, Wheeler DC, Tsukamoto Y, Fukagawa M.Kidney Int Rep. 2019 Sep 23;4(11):1523-1537. doi: 10.1016/j.ekir.2019.09.007. eCollection 2019 Nov. 
  27. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.Zheng CM, Wu CC, Lu CL, Hou YC, Wu MS, Hsu YH, Chen R, Chang TJ, Shyu JF, Lin YF, Lu KC*.Int J Med Sci. 2019 Oct 21;16(12):1583-1592. doi: 10.7150/ijms.39158. eCollection 2019. 
  28. Association between regional economic status and renal recovery of dialysis-requiring acute kidney injury among critically ill patients.Shiao CC, Chang YH, Yang YF, Lin ET, Pan HC, Chang CH, Huang CT, Kao MT, Chuang TF, Chen YC, Kan WC, Kuo FC, Chen TC, Chen YM, Wu CJ, Liou HH, Lu KC, Wu VC, Chu TS, Wu MS, Wu KD, Fang JT, Huang CC.Sci Rep. 2020 Sep 3;10(1):14573.
  29.  Antiproteinuria Effect of Calcitriol in Patients With Chronic Kidney Disease and Vitamin D Deficiency: A Randomized Controlled Study.Wu CC, Liao MT, Hsiao PJ, Lu CL, Hsu YJ, Lu KC, Chu P.J Ren Nutr. 2020 May;30(3):200-207. doi: 10.1053/j.jrn.2019.09.001.  
  30. The Paradoxical Role of Uric Acid in Osteoporosis.Lin KM, Lu CL, Hung KC, Wu PC, Pan CF, Wu CJ, Syu RS, Chen JS, Hsiao PJ, Lu KC*.Nutrients. 2019 Sep 5;11(9). pii: E2111. doi: 10.3390/nu11092111. Review. 
  31. Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.Zheng CM, Hsu YH, Wu CC, Lu CL, Liu WC, Zheng JQ, Lin YF, Chiu HW, Chang TJ, Shyu JF, Lu KC*.Int J Mol Sci. 2019 Jun 8;20(11). pii: E2800. doi: 10.3390/ijms20112800. 
  32. Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population.Zheng CM, Wang JY, Chen TT, Wu YC, Wu YL, Lin HT, Chiu SP, Chang TJ, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Wu MY, Lin YF.Sci Rep. 2019 Feb 25;9(1):2694. doi: 10.1038/s41598-019-38991-z.  
  33. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification.Hou YC, Lu CL, Zheng CM, Chen RM, Lin YF, Liu WC, Yen TH, Chen R, Lu KC*Nutrients. 2019 Jan 12;11(1). pii: E152 
  34. The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD. Lu CL, Yeih DF, Hou YC, Jow GM, Li ZY, Liu WC, Zheng CM, Lin YF, Shyu JF, Chen R, Huang CY, Lu KC*.Nutrients. 2018 Dec 3;10(12). pii: E1890 
  35. Mineral bone disorders in chronic kidney disease.Hou YC, Lu CL, Lu KC*.Nephrology (Carlton). 2018 Oct;23 Suppl 4:88-94 
  36. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.Liu WC, Tomino Y, Lu KC*.Toxins (Basel). 2018 Sep 11;10(9). pii: E367 
  37. Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion.Lu CL, Shyu JF, Wu CC, Hung CF, Liao MT, Liu WC, Zheng CM, Hou YC, Lin YF, Lu KC*.Nutrients. 2018 Aug 25;10(9). pii: E1164 
  38. Effect of mechanistic target of rapamycin inhibitors on postrenal transplantation malignancy: A nationwide cohort study.Hou YC, Chang YC, Luo HL, Lu KC, Chiang PH.Cancer Med. 2018 Sep;7(9):4296-4307 
  39. Effect of uremic toxin-indoxyl sulfate on the skeletal system. Liu WC, Wu CC, Lim PS, Chien SW, Hou YC, Zheng CM, Shyu JF, Lin YF, Lu KC*.Clin Chim Acta. 2018 Sep;484:197-206. 
  40. Role of nutritional vitamin D in osteoporosis treatment.Hou YC, Wu CC, Liao MT, Shyu JF, Hung CF, Yen TH, Lu CL, Lu KC*.Clin Chim Acta. 2018 May 18; 484: 179-191 
  41. Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population.Chang TJ, Zheng CM, Wu MY, Chen TT, Wu YC, Wu YL, Lin HT, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Lin YF.Sci Rep. 2018 May 2; 8(1): 6908 
  42. Role of resilience and social support in alleviating depression in patients receiving maintenance hemodialysis.Liu YM, Chang HJ, Wang RH, Yang LK, Lu KC, Hou YC.Ther Clin Risk Manag. 2018 Mar 1; 14: 441-451
  43. Role of MTNR1A and PITX1 coexpression in protecting tubular epithelial cells in membranous nephropathy.Huang YS, Lu KC, Chao TK, Chen JS, Chen A, Guo CY, Hsieh HY, Shih HM, Sytwu HK, Wu CCJ Pineal Res. 2018 Feb 26. doi: 10.1111/jpi.12482 
  44. Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.Zheng CM, Wu CC, Hung CF, Liao MT, Shyu JF, Hsu YH, Lu CL, Wang YH, Zheng JQ, Chang TJ, Lin YF, Lu KC*.Nutrients. 2018 Feb 10; 10(2). pii: E196. doi: 10.3390/nu10020196. 
  45. Challenges of measuring the Healthcare Access and Quality Index.Wu CC, Hwang SJ, Hsu CC, Lu KC*; Taiwan Society of Nephrology.Lancet. 2018 Feb 3; 391(10119): 428-429 
  46. Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy.Huang YS, Fu SH, Lu KC, Chen JS, Hsieh HY, Sytwu HK, Wu CC.Oncotarget. 2017 Dec 4; 8(67): 111631-111641 
  47. Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology.Chiu HF, Chen HC, Lu KC, Shu KH; Taiwan Society of Nephrology.BMC Nephrol. 2018 Jan 10; 19(1): 6 
  48. Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease.Su SL, Chen WT, Hsiao PJ, Lu KC, Lin YF, Lin C, Su W, Yeh SJ, Chang H, Lin FH.Oncotarget. 2017 Oct 26;8(64):107833-107843 
  49. Association of stroke subtypes with risk of hip fracture: a population-based study in Taiwan.Zheng JQ, Lai HJ, Zheng CM, Yen YC, Lu KC, Hu CJ, Lee HH, Wang YH.Arch Osteoporos. 2017 Nov 22;12(1):104 
  50. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF.J Bone Miner Metab. 2017 Oct 5. doi: 10.1007/s00774-017-0866-z 
  51. A chronic hemodialysis patient with isolated pulmonary valve infective endocarditis caused by non-albicans Candida: a rare case and literature review.Chang CH, Huang MM, Yeih DF, Lu KC, Hou YC.BMC Nephrol. 2017 Sep 6;18(1):286. 
  52. Role of Vitamin D in Uremic Vascular Calcification.  Hou YC, Liu WC, Zheng CM, Zheng JQ, Yen TH, Lu KC*.  Biomed Res Int. 2017; 2017: 2803579.  
  53. Music therapy-induced changes in salivary cortisol level are predictive of cardiovascular mortality in patients under maintenance hemodialysis. Hou YC, Lin YJ, Lu KC, Chiang HS, Chang CC, Yang LK.   Ther Clin Risk Manag. 2017 Feb 23; 13: 263-272. 
  54. A comparison of efficacy of endovascular versus surgical repair for the treatment of arteriovenous fistula stenosis in Taiwan.  Fan SS, Chen CW, Lu KC, Mao HC, Chen MP, Chou CL.  J Vasc Access. 2017 Feb 15:0. doi: 10.5301/jva.5000669.  
  55. Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients. Zheng JQ, Hou YC, Zheng CM, Lu CL, Liu WC, Wu CC, Huang MT, Lin YF, Lu KC*. 2016 Nov 5; 8(11). pii: E708. 
  56. Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods.   Shiao CC, Wu PC, Wu VC, Lin JH, Pan HC, Yang YF, Lai TS, Huang TM, Wu CH, Yang WS, Wu CJ, Kao CC, Sun CY, Huang CT, Lee KH, Lin CY, Chen TC, Hu FC, Liou HH, Lu KC, Chien KL, Wang JJ, Kan WC, Kuo FC, Lin HY, Chen CM, You ZH, Tsai JP, Weng CJ, Chen HY, Chang CF, Hsu WD, Wu MS, Huang CC, Wu KD; Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs). Nephrology (Carlton). 2016 Sep; 21(9):758-64. 
  57. Intradialytic aerobic cycling exercise alleviates inflammation and improves endothelial progenitor cell count and bone density in hemodialysis patients. Liao MT, Liu WC, Lin FH, Huang CF, Chen SY, Liu CC, Lin SH, Lu KC*, Wu CC. Medicine (Baltimore). 2016 Jul; 95(27): e4134.  
  58. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.  Shen CH, Zheng CM, Kiu KT, Chen HA, Wu CC, Lu KC, Hsu YH, Lin YF, Wang YH.                    Medicine (Baltimore). 2016 Jun; 95(25):e3933.  
  59. Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis.  Lu CL, Ma WY, Lin YF, Shyu JF, Wang YH, Liu YM, Wu CC, Lu KC*.  Int J Med Sci. 2016 May 10; 13(5): 395-402.  
  60. Bone loss in chronic kidney disease: Quantity or quality?   Zheng CM, Zheng JQ, Wu CC, Lu CL, Shyu JF, Yung-Ho H, Wu MY, Chiu IJ, Wang YH, Lin YF, Lu KC*.  2016 Jun; 87: 57-70. doi: 10.1016/j.bone.2016.03.017.  
  61. Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients. Lu CL, Leu JG, Liu WC, Zheng CM, Lin YF, Shyu JF, Wu CC, Lu KC*.  Int J Med Sci. 2016 Feb 20;13(3):240-7. doi: 10.7150/ijms.14209.  
  62. Pleiotropic effects of vitamin D in chronic kidney disease.  Liu WC, Wu CC, Hung YM, Liao MT, Shyu JF, Lin YF, Lu KC*, Yeh KC.  Clin Chim Acta. 2016 Jan 30; 453: 1-12. doi: 10.1016/j.cca.2015.11.029.   
  63. The Association of Losartan and Ramipril Therapy With Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: A Chinese Nation-Wide Cohort Study in Taiwan.   Hsing SC, Lu KC, Sun CA, Chien WC, Chung CH, Kao SY.  Medicine (Baltimore). 2015 Dec; 94(48): e1999.  
  64. Vitamin D and immune function in chronic kidney disease.   Liu WC, Zheng CM, Lu CL, Lin YF, Shyu JF, Wu CC, Lu KC*.  Clin Chim Acta. 2015 Oct 23; 450: 135-44. doi: 10.1016/j.cca.2015.08.011.  
  65. 99mTc-TRODAT-1 SPECT as a Potential Neuroimaging Biomarker in Patients With Restless Legs Syndrome.  Lin CC, Fan YM, Lin GY, Yang FC, Cheng CA, Lu KC, Lin JC, Lee JT.  Clin Nucl Med. 2016 Jan; 41(1): e14-7.  
  66. Risk factors and their interaction on chronic kidney disease: A multi-centre case control study in Taiwan.  Su SL, Lin C, Kao S, Wu CC, Lu KC, Lai CH, Yang HY, Chiu YL, Chen JS, Sung FC, Ko YC, Lee CT, Yang Y, Yang CW, Hwang SJ, Wang MC, Hsu YH, Wu MY, Hsueh YM, Chiou HY, Lin YF.  BMC Nephrol. 2015 Jun 16; 16: 83. doi: 10.1186/s12882-015-0065-x.